Dinapsoline

N/A

Report date: 2023/02/20 18:00:49
NME

Base Information

Drug NameDinapsoline
Drug Alias NameDAR-200DAR-0200ADAR-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor agonists
TargetsDopamine D1 receptor
Therapy Area/IndicationsSchizophreniaParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDarpharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDarpharma
Active IndicationsN/A
Inactive IndicationsSchizophreniaParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A